代谢性骨病的细胞基础。 - Suppr

Suppr

超能文献

The cellular basis of metabolic bone disease.

作者信息

Rasmussen H, Bordier P

出版信息

N Engl J Med. 1973 Jul 5;289(1):25-32. doi: 10.1056/NEJM197307052890107.

DOI:10.1056/NEJM197307052890107

PMID:4575395

Abstract

摘要

相似文献

The cellular basis of metabolic bone disease.

N Engl J Med. 1973 Jul 5;289(1):25-32. doi: 10.1056/NEJM197307052890107.

Immunolocalization of the prostaglandin E2 receptor subtypes in human bone tissue: differences in foetal, adult normal, osteoporotic and pagetic bone.

Prostaglandins Leukot Essent Fatty Acids. 2004 May;70(5):431-9. doi: 10.1016/j.plefa.2003.08.024.

Skeletal renewal and metabolic bone disease.

N Engl J Med. 1969 Feb 6;280(6):303-11 concl. doi: 10.1056/NEJM196902062800605.

Interaction between osteoblast and osteoclast: impact in bone disease.

Histol Histopathol. 2004 Oct;19(4):1325-44. doi: 10.14670/HH-19.1325.

Bone histology in metabolic bone disease: the diagnostic value of bone biopsy.

Orthop Clin North Am. 1979 Apr;10(2):329-45.

Quantitative study of tunneling and hook resorption in metabolic bone disease.

Calcif Tissue Int. 1981;33(5):459-66. doi: 10.1007/BF02409474.

Secondary hyperparathyroidism.

Mt Sinai J Med. 1973 May-Jun;40(3):462-73.

Immunohistochemical localization of the prostacyclin receptor (IP) human bone.

Prostaglandins Leukot Essent Fatty Acids. 2001 Aug;65(2):79-83. doi: 10.1054/plef.2001.0292.

The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part III of IV parts; PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism.

Metabolism. 1976 Sep;25(9):1033-69. doi: 10.1016/0026-0495(76)90133-5.

[Regulation of bone metabolism and metabolic bone diseases].

Vutr Boles. 1977;16(3):8-14.

引用本文的文献

Osteoclast-derived coupling factors: origins and state-of-play Louis V Avioli lecture, ASBMR 2023.

J Bone Miner Res. 2024 Sep 26;39(10):1377-1385. doi: 10.1093/jbmr/zjae110.

The Decline of Paget's Disease of Bone and Domestic Coal Use-A Hypothesis.

Calcif Tissue Int. 2024 Aug;115(2):117-123. doi: 10.1007/s00223-024-01241-0. Epub 2024 Jun 20.

Cyclophilin A (CypA) Plays Dual Roles in Regulation of Bone Anabolism and Resorption.

Sci Rep. 2016 Mar 2;6:22378. doi: 10.1038/srep22378.

NELL-1 in the treatment of osteoporotic bone loss.

Nat Commun. 2015 Jun 17;6:7362. doi: 10.1038/ncomms8362.

The spine in Paget's disease.

Skeletal Radiol. 2007 Jul;36(7):609-26. doi: 10.1007/s00256-006-0270-6. Epub 2007 Apr 5.

Periosteocyte demineralization in disuse osteoporsis. The effect of calcitonin.

Int Orthop. 1981;5(4):299-304. doi: 10.1007/BF00271086.

Treatment of Paget's disease of bone with synthetic salmon calcitonin.

Br Med J. 1974 Sep 21;3(5933):727-31. doi: 10.1136/bmj.3.5933.727.

Osteoporosis: diagnosis and treatment.

Drugs. 1974;8(4):290-306. doi: 10.2165/00003495-197408040-00004.

A review of recent experimental work on the dental cyst.

Proc R Soc Med. 1974 Dec;67(12 Pt 1):1259-63. doi: 10.1177/003591577406712P130.

Mithramycin therapy in Paget's disease.

Can Med Assoc J. 1974 Feb 16;110(4):397-400.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验